![Moshe Arkin](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Moshe Arkin
Vorstandsvorsitzender bei
SOL-GEL TECHNOLOGIES LTD.
Vermögen: 179 Mio $ am 30.06.2026
Profil
Moshe Arkin is the founder of Arkin Bio Ventures, founded in 2009, serving as Chairman since its founding.
Mr. Arkin is the founder of Arkin Holdings Ltd., founded in 2009, serving as Chairman since its founding.
Mr. Arkin is also the founder of SoniVie Ltd...
Current jobs include Executive Chairman & Chief Executive Officer at Sol-Gel Technologies Ltd. starting 2025, Chairman at Mobile Solid Ltd. since 2006, Chairman at Accelmed Partners II Management, LLC since 2010, Director at M.
Arkin (1999) Ltd., Director at Odysight.ai, Inc. since 2021, Director at Arkin Communications Ltd., Director at N.L.T Spine Ltd., Director at Meridian Bioscience Israel Ltd. since 2006, Director at Accelmed Ventures, Director at NanoDoc Biotechnology Ltd., Director at Digma Medical Ltd. since 2013, and Director at Arkin Assets Ltd. Former jobs include Vice Chairman at Perrigo Co. from 2008 to 2011, Chairman at Bezeq The Israeli Telecommunication Corp.
Ltd. in 2007, Chairman at HealOr Ltd., Vice Chairman at Perrigo UK Ltd. from 2005 to 2008, Chairman at Agis Industries (1983) Ltd. from 1972 to 2005, Director at Ophthalmic Imaging Systems, Inc., Director at Edge Medical Devices Ltd., Director at Blue Wave Water Capital Ltd., Director at cCAM Biotherapeutics Ltd. from 2012 to 2015, Director at Quiet Therapeutics Ltd., Director at EndoSpan Ltd., Director at ValCare Medical, Inc., and President at Perrigo Israel Pharmaceuticals Ltd. from 1983 to 2008.
Education includes undergraduate studies at Tel-Aviv University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 25.03.2026 | 1’950’113 ( 59.65% ) | 145 Mio $ | 30.06.2026 | |
ODYSIGHT.AI INC. 33.22% | 25.03.2026 | 5’583’981 ( 33.22% ) | 23 Mio $ | 30.06.2026 |
Novolog (Pharm UP 1966) Ltd.
 Novolog (Pharm UP 1966) Ltd. Medical DistributorsDistribution Services Wholesales pharmaceutical products 8.6% | 30.06.2025 | 43’921’649 ( 8.6% ) | 11 Mio $ | 30.06.2026 |
Aktive Positionen von Moshe Arkin
| Unternehmen | Position | Beginn |
|---|---|---|
| EXALENZ BIOSCIENCE LTD | Direktor/Vorstandsmitglied | 01.01.2006 |
| SOL-GEL TECHNOLOGIES LTD. | Vorstandsvorsitzender | 01.01.2025 |
| INTELLISENSE SOLUTIONS INC | Direktor/Vorstandsmitglied | 15.02.2021 |
NanoDoc Biotechnology Ltd.
 NanoDoc Biotechnology Ltd. Medical SpecialtiesHealth Technology Develops therapy for diseases such as cancer | Direktor/Vorstandsmitglied | - |
Arkin Holdings Ltd. | Gründer | 01.01.2009 |
Digma Medical Ltd.
 Digma Medical Ltd. Pharmaceuticals: MajorHealth Technology Develops solutions to metabolic diseases | Direktor/Vorstandsmitglied | 14.08.2013 |
SoniVie Ltd.
 SoniVie Ltd. Medical SpecialtiesHealth Technology Develops intravascular ultrasound systems | Gründer | - |
Arkin Assets Ltd. | Direktor/Vorstandsmitglied | - |
Accelmed Ventures
 Accelmed Ventures Investment ManagersFinance Accelmed Ventures invests in companies located in the US. The firm focuses on broad range of sectors. It participated in seed and early stage capital transactions. | Direktor/Vorstandsmitglied | - |
| ░░ ░░░░░ ░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | - |
| ░░░░░ ░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | - |
Ehemalige bekannte Positionen von Moshe Arkin
| Unternehmen | Position | Ende |
|---|---|---|
| ░░░░ ░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░ ░░░░░░░ ░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░ ░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
Ausbildung von Moshe Arkin
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
64
Beziehungen ersten Grades
29
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 29 |
|---|---|
Perrigo Co.
 Perrigo Co. Pharmaceuticals: MajorHealth Technology Manufactures, distributes and markets pharmaceutical and nutritional products | Health Technology |
Ophthalmic Imaging Systems, Inc.
 Ophthalmic Imaging Systems, Inc. Medical SpecialtiesHealth Technology Manufactures ophthalmic digital imaging systems | Health Technology |
Perrigo Israel Pharmaceuticals Ltd.
 Perrigo Israel Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Develops and markets generic products and pharmaceutical ingredients | Health Technology |
M. Arkin (1999) Ltd. | |
Odysight.ai, Inc.
 Odysight.ai, Inc. Electronics/AppliancesConsumer Durables Develops, manufactures and markets customized visual solutions composed of imaging equipment, cloud and software based image processing for medical industry | Consumer Durables |
Bezeq The Israeli Telecommunication Corp. Ltd.
 Bezeq The Israeli Telecommunication Corp. Ltd. Major TelecommunicationsCommunications Provides telecommunication services | Communications |
Sol-Gel Technologies Ltd.
 Sol-Gel Technologies Ltd. Pharmaceuticals: MajorHealth Technology Engages in the identification, development, and commercialization of topical dermatological drug products for the treatment of skin diseases | Health Technology |
Tel-Aviv University
 Tel-Aviv University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Edge Medical Devices Ltd.
 Edge Medical Devices Ltd. Medical SpecialtiesHealth Technology Develops and manufactures digital x-ray detectors | Health Technology |
Arkin Communications Ltd.
 Arkin Communications Ltd. Financial ConglomeratesFinance Investment holding company | Finance |
HealOr Ltd.
 HealOr Ltd. Pharmaceuticals: MajorHealth Technology Develops and commercializes proprietary biochemical regulatory therapeutics | Health Technology |
Pharmocann Global Ltd.
 Pharmocann Global Ltd. Medical SpecialtiesHealth Technology Engages in non-invasive solutions for the prevention of venous thromboembolism | Health Technology |
N.L.T Spine Ltd.
 N.L.T Spine Ltd. Medical SpecialtiesHealth Technology Develops spine surgery instrumentation and implants for treating degenerative spinal conditions | Health Technology |
Perrigo UK Ltd.
 Perrigo UK Ltd. Pharmaceuticals: GenericHealth Technology Manufactures and packages vitamins, minerals, supplements, and licensed medicines | Health Technology |
Meridian Bioscience Israel Ltd.
 Meridian Bioscience Israel Ltd. Medical SpecialtiesHealth Technology Manufactures gastrointestinal diagnostic systems for diagnosing and managing in the fields of liver and GI health | Health Technology |
Mobile Solid Ltd. | |
Accelmed Partners II Management, LLC
 Accelmed Partners II Management, LLC Investment ManagersFinance Accelmed Partners invests in lower middle market companies located in the United States and Europe. The firm targets companies operating in the fields of medical devices, diagnostics, digital health and technology enabled services. It provides financing for buyout and growth stage capital requirements with an investment size of USD 20 - 40 million. The firm acquires controlling and non-controlling interests and makes co-investments. It acts as a lead investor and takes a seat on the board of directors and also makes follow on investments. | Finance |
Agis Industries (1983) Ltd.
 Agis Industries (1983) Ltd. Pharmaceuticals: GenericHealth Technology Develops and manufactures generic pharmaceuticals and active pharmaceutical ingredients | Health Technology |
cCAM Biotherapeutics Ltd.
 cCAM Biotherapeutics Ltd. Pharmaceuticals: MajorHealth Technology Discovers, develops and markets novel immunotherapy to treat cancer | Health Technology |
Quiet Therapeutics Ltd.
 Quiet Therapeutics Ltd. Medical SpecialtiesHealth Technology Develops a proprietary nanoparticle-based delivery system for the targeted delivery of chemotherapy and anti-inflammatory drugs | Health Technology |
Accelmed Ventures
Accelmed Ventures Investment ManagersFinance Accelmed Ventures invests in companies located in the US. The firm focuses on broad range of sectors. It participated in seed and early stage capital transactions. | Finance |
ValCare Medical, Inc.
 ValCare Medical, Inc. Medical SpecialtiesHealth Technology Engages in the designing, developing and commercializing devices and accessories for minimally invasive treatment of heart valve diseases | Health Technology |
EndoSpan Ltd.
 EndoSpan Ltd. Pharmaceuticals: MajorHealth Technology Develops novel endovascular system for endovascular aortic aneurysm repair | Health Technology |
NanoDoc Biotechnology Ltd.
NanoDoc Biotechnology Ltd. Medical SpecialtiesHealth Technology Develops therapy for diseases such as cancer | Health Technology |
Digma Medical Ltd.
Digma Medical Ltd. Pharmaceuticals: MajorHealth Technology Develops solutions to metabolic diseases | Health Technology |
Arkin Assets Ltd. | |
SoniVie Ltd.
SoniVie Ltd. Medical SpecialtiesHealth Technology Develops intravascular ultrasound systems | Health Technology |
Arkin Bio Ventures
 Arkin Bio Ventures Investment ManagersFinance Arkin Bio focuses its investment efforts in life science companies located across the globe, mainly in Israel. The firm targets businesses operating in the biotechnology and pharmaceutical sector. It provides financing for early to mid-stage capital requirements. | Finance |
Arkin Holdings Ltd. |
